Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

Computed Tomography Simulation for Gamma Knife Radiosurgery: Impact on Target Coverage
Yaddanapudi, Sridhar , Herchko, Steven, Shrestha, Deepak K. , Gianforti, Bonita L., Kopacka, Kathleen A., Lane, Kayla M., Harrell, Anna , Fox, W. Christopher , Peterson, Jennifer , Harrell, Anna C , Yaddanapudi, Sridhar , Lane, Kayla M., Grewal, Sanjeet S. , Trifiletti, Daniel M.

Journal of Medical Physics | July 3, 2025 | Volume: 50 | Issue: 2 | Pages: 415-418

10.4103/jmp.jmp_193_24 | PMID 41939148 Get It

This study evaluated the effectiveness of using a traditional computed tomography (CT) simulation scan in the Leksell Gamma Knife® Icon™ workflow for stereotactic radiosurgery. We compared two workflows, one involving a traditional CT simulation co-registered with the magnetic resonance imaging (MRI) and cone-beam CT (CBCT) (MRI-CT-CBCT) and another without the CT scan, co-registering the MRI directly with CBCT (MRI-CBCT). The cohort included 50 frame-based (54 targets) and 55 frameless (124 targets) patients treated between August 2020 and December 2022. Target coverage was assessed by the percentage of each target covered by the prescription isodose line. The mean coverage differences for the frame-based and frameless cohorts were −1.20% ± 1.43% and −1.06% ± 1.51%, respectively, with 95% confidence intervals of −1.59, −0.81 and −1.32, −0.79. The MRI-CBCT workflow was deemed noninferior to the MRI-CT-CBCT workflow. Our data indicate that both workflows yield similar results, suggesting that a traditional CT simulation scan is unnecessary.
Prevalence of Second Victim Experiences in a Cohort of Healthcare Learners and the Impact on Their Well-Being
Torbenson, Vanessa E. , Riggan, Kirsten A. , Stonnington, Cynthia M. , Huang, Lily , Perlman, Adam , Vadeboncoeur, Tyler F. , Allyse, Megan , Finney, Robyn E. , Rivera‐Chiauzzi, Enid Y. , Abu Dabrh, Abd Moain , Perlman, Adam , Vadeboncoeur, Tyler F , Allyse, Megan A , Finney, Robyn E , Rivera-Chiauzzi, Enid Y , Riggan, Kirsten A , Dabrh, Abd Moain Abu

Journal of Medical Education and Curricular Development | July 3, 2025 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/23821205251340434 | PMID 40620328 Get It

Objectives This study identified the prevalence of second victim experience (SVE) in a multidisciplinary sample of healthcare learners and explored personal experiences of trauma and desired forms of support following traumatic patient care events or situations. Method We used the validated SVE Support Tool-Revised and the Physician Well-Being Index (PWBI) to query healthcare learners at a large academic health system across the institution's medical, graduate medical education, and health sciences schools. The survey was open to all healthcare learners from April 8th, 2022 to May 30th, 2022. Here, we report on an analysis of respondents’ fixed responses describing the prevalence and characteristics of SVE. Results Of 2298 potential respondents, 206 answered at least one question (9.0% response rate). Of the 206 respondents, 205 answered questions inquiring if they had been a part of a stressful or traumatic patient care event or situation and 54.1% (111/205) answered in the affirmative. Of this group, 49.5% (51/103) reported feeling like a second victim (SV). The average PWBI of the exposed group was significantly higher (worse well-being) than the nonexposed group (3.4 vs 2.6, P = .0009). The most common forms of desired support for those exposed to a traumatic event and felt like an SV was conversation with peers 95.3% (41/43), family 81.4% (35/43), and a supervisor or manager 67.4% (29/43). Conclusion Findings suggest that many healthcare learners experience SVE and would benefit from connection to desired support strategies. Strategies to mitigate the impact of SVE on professional self-efficacy should be considered by education administrators. We present strategies from the literature and our institution that may be replicated for early identification and support of learners with SVE.
Epilepsy Care in the Real World of Multiple Medical Considerations
Klocke, Shilpa , Eyal, Sara , Dubey, Divyanshu , Alick-Lindstrom, Sasha , Das, Rohit , Eyal, Sara , Alick-Lindstrom, Sasha , Das, Rohit R , Dubey, Divyanshu , Stern, John M. , Lekoubou, Alain

Epilepsy Currents | July 3, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/15357597251320144 | PMID 40621489 Get It

Similar to the general population, people with epilepsy (PWE) will often have multiple medical issues that may impact their care. It is therefore important for epilepsy clinicians to be aware of these issues to optimize treatment and quality of life outcomes. In this review, we discuss cardiovascular and respiratory as well as infectious disorders in PWE. We also examine autoimmune disorders and outline reproductive and sexual health issues.
Roles, responsibilities, and opportunities for the nutrition support physician working with adults: A critical review
Mundi, Manpreet S. , Mechanick, Jeffrey I. , Patel, Jayshil J. , Newberry, Carolyn , Sankararaman, Senthilkumar , Rosenthal, Martin D. , Bering, Jamie , Katz, Jennifer, Stoppe, Christian , Mechanick, Jeffrey I. , Patel, Jayshil J , Rosenthal, Martin , Mohamed Elfadil, Osman , Bering, Jamie L , Katz, Jennifer , Stoppe, Christian , Martindale, Robert , McClave, Stephen A , Mundi, Manpreet S , Elfadil, Osman Mohamed , Martindale, Robert G. , McClave, Stephen A.

Journal of Parenteral and Enteral Nutrition | July 3, 2025 | Volume: 49 | Issue: 7 | Pages: 816-835

10.1002/jpen.2790 | PMID 40605397 Get It

AbstractThe dual burden of undernutrition and overnutrition requires a greater understanding and commitment to physician training and specialization in nutrition support. Despite the significant healthcare need and existence of organizations focused on nutrition support such as the American Society for Parenteral and Enteral Nutrition (ASPEN), physician involvement in the nutrition care of high‐risk patients remains low. In an ASPEN survey of members, inadequate training among physicians was reported along with significant barriers to involvement in nutrition support, such as insufficient protected time, reduced reimbursement and financial support, inadequate support from administrators or supervisors, as well as a nationwide reduction in number of nutrition support teams. These changes in the healthcare landscape prompted the ASPEN Physician Engagement Committee to develop a critical review focused on domains of nutrition risk assessment, enteral and parenteral access and support, scholarly activities, board certification, administrative responsibilities, education and training opportunities, coding, and reimbursement. The aim of this critical review is to capacitate physicians to engage in nutrition support and enhance their acumen in clinical nutrition to improve patient care and enrich personal and professional development.
Condylomatous Sinonasal Papilloma—A Distinct (Fourth) Subtype That is Commonly Associated With Low-risk Human Papillomavirus
Mehreen, Ansa , Mehrad, Mitra , Ely, Kim, Kuo, Ying‐Ju , Velez-Torres, Jaylou M., Penner, Carla, Amin, Sara E. , Saluja, Karan , Lewis, James S. , Lewis, James S , Hang, Jen‐Fan , Chernock, Rebecca

American Journal of Surgical Pathology | July 3, 2025 | Volume: 49 | Issue: 9 | Pages: 873-881

10.1097/pas.0000000000002431 | PMID 40605275 Get It

Inverted papilloma (IP) is a benign neoplasm of the nasal cavity and paranasal sinuses, known for its variable risk of recurrence and potential for developing carcinoma. Emerging evidence has shown high rates of activating EGFR mutation, and a smaller subset is associated with low-risk human papillomavirus (lrHPV). While certain morphologic features, including an inverted growth pattern, are well-established, the presence of condylomatous features, such as large fungating lesions with thick undulating surface epithelium, hyperkeratosis, cytoplasmic clearing, raisinoid nuclei, and binucleation (koilocytic changes) in low-risk HPV-associated IP suggests that these tumors may be a distinct subtype of sinonasal papilloma (SP) with features similar to low-risk HPV-associated anogenital condylomas. This study presents a series of SP with condylomatous morphology and explores the association with lrHPV, the clinicopathologic features, and the rates of carcinoma development. In total, 17 cases of SP exhibiting condylomatous morphology were retrospectively identified. We performed lrHPV and high-risk HPV (hrHPV) RNA in situ hybridization and p16 immunohistochemistry and gathered detailed clinical and pathologic data along with treatment, disease follow-up, and outcomes. These condylomatous papillomas almost all developed in active smokers, were large, were primarily located in the nasal cavity (47%), and showed frequent transformation to invasive squamous cell carcinoma (29%). This malignant transformation rate is much higher than what has been reported for inverted, exophytic, and oncocytic papillomas. The tumors were almost uniformly associated with transcriptionally-active lrHPV (94%) and were consistently negative for p16 and hrHPV. This study shows that a subgroup of IPs with condylomatous morphology have a predilection for the nasal cavity, strong association with lrHPV, and high rates of carcinoma. These findings support the concept that these tumors are a distinct (fourth) type of SP with a higher risk of malignant transformation.
The Minnesota Conference proposed guidelines for education and training in clinical neuropsychology
Stringer, Anthony Y. , Fuchs, Kathleen , Edgar, Veronica Bordes , Correia, Stephen , Penna, Suzanne , Whiteside, Douglas M. , Bodin, Douglas, Butt, Sakina M. , Dodzik, Peter , Fernandes, Mary A. , Freece, Krista, Fuller, Richard, Getz, Glen E., Harder, Lana , Irani, Farzin , Janzen, Laura , Kaseda, Erin T. , Kramer, Megan , Kubu, Cynthia S. , Lafosse, Jose M., Lee-DaRocha, Jennifer, MacDonald, Beatriz , Strutt, Adriana M. , McBride, W.E., Mucci, Grace , Nayar, Kritika , Paltzer, June Yu, Ray, Courtney , Ready, Rebecca E. , Schmitt, Taylor Rose , Rush, Beth , Stanford, Lisa D., Patten, Ryan Van , Verroulx, Kris, Wilson, Jaime, Wright, Ingram , Zartman, Andrea L., Fujii, Daryl , Heffelfinger, Amy , Rey‐Casserly, Celiane , Whiteside, Douglas , Block, Cady, Calamia, Matthew , M Dotson, Vonetta , Johnstone, Brick , Kaseda, Erin , Madore, Michelle , Medina, Luis Daniel , Sperling, Scott , Stiers, William , Stricker, Nikki H , Bilder, Robert , Heffelfinger, Amy , Schmitter-Edgecombe, Maureen , Bristow, Thomas, Reyes, Anny , Block, Cady K. , Calamia, Matthew , Didehbani, Nyaz , Fuller, Richard, Harder, Lana, McBride, Will, Medina, Luis D. , Singh, Shifali M. , Sperling, Scott A. , Stricker, Nikki H. , Thornton, Allen E. , Vandermorris, Susan , Parsons, Thomas D. , Puente, Antonio E. , Roper, Brad L.

The Clinical Neuropsychologist | July 2, 2025 | Volume: 40 | Issue: 2 | Pages: 331-375

10.1080/13854046.2025.2520957 | PMID 40604361 Get It

Kidney organoids demonstrate that PTH1R drives a cystogenic cAMP-pPKA-pCREB axis in developmental polycystic kidney disease
Afrin, Humayra , Robichaud, Jielu Hao, Harris, Peter C. , Gupta, Navin , Gupta, Navin , Harris, Peter C , Robichaud, Jielu Hao, Qamar, Usama

American Journal of Physiology-Renal Physiology | July 2, 2025 | Volume: 329 | Issue: 2 | Pages: F257-F268

10.1152/ajprenal.00056.2025 | PMID 40602764 Get It

Stem cell-derived kidney organoids enable human genetic disease modeling to identify the parathyroid hormone 1 receptor as a potential new therapeutic target for developmental polycystic kidney disease.
Early Stroke Detection: A Mobile Application for Real-Time Stroke Diagnosis Using Video and Lightweight Deep Learning
Elhanashi, Abdussalam , Donati, Massimiliano , Yuankai, Huo, Kuanar, Shiba , Ünal, Orhan , Saponara, Sergio , Zheng, Qinghe , Singh, Yashbir , Ali, Farzana , Younis, Khaled S.

2025 19th International Symposium on Medical Information and Communication Technology (ISMICT) | July 2, 2025 | Volume: No volume available | Issue: No issue available | Pages: 1-6

10.1109/ismict64722.2025.11059411 Get It

Oral Vancomycin for Prevention of Recurrent Clostridioides difficile Infection
Keating, Julie A. , Xu, Tinghui , Graham, Mary Beth, Ramesh, Mayur , Khanna, Sahil , Dixon, Jonah, Haight, Kendra , Zhao, Jiwei , Safdar, Nasia , Kates, Ashley , Saddler, Christopher M.

JAMA Network Open | July 2, 2025 | Volume: 8 | Issue: 7 | Pages: e2517834

10.1001/jamanetworkopen.2025.17834 | PMID 40601321 Get It

ImportanceSystemic antibiotic use for patients with a non–Clostridioides difficile infection (CDI) is a major risk factor for recurrent CDI. Increasing use of oral vancomycin for secondary prophylaxis against recurrent CDI in this context has uncertain efficacy.ObjectiveTo evaluate whether oral vancomycin prophylaxis compared with placebo is effective against recurrent CDI during and 8 weeks after the end of study treatment.Design, Setting, and ParticipantsThis phase 2, placebo-controlled, double-blind randomized clinical trial was conducted in 4 large health systems across the upper Midwest US. Adults who had completed treatment for CDI within the past 180 days and were taking a systemic antibiotic for a non-CDI indication were enrolled between May 21, 2018, and March 30, 2023, and followed up for 8 weeks after the end of study treatment.InterventionParticipants were randomized 1:1 to 125 mg of oral vancomycin or placebo once daily during antibiotic use for a non-CDI plus 5 days following cessation of those antibiotics.Main Outcomes and MeasuresThe primary outcome was recurrent CDI incidence during treatment and the 8-week follow-up period. The secondary outcome was vancomycin-resistant Enterococcus carriage in stool.ResultsAmong 81 randomized participants (median age, 59 years [IQR, 50-67 years]), all were included in the primary as-randomized analysis (39 in the vancomycin group; 42 in the placebo group). Sixty patients (74.1%) completed 8-week follow-up and were included in the secondary as–completed treatment analysis (31 in the vancomycin group; 29 in the placebo group). Recurrent CDI occurred in 17 of 39 participants in the oral vancomycin group (43.6%) and 24 of 42 in the placebo group (57.1%; absolute difference in percentage, −13.5% [95% CI, −35.1% to 8.0%]). Adverse events occurred in 27 of 39 participants in the oral vancomycin group (69.2%) and 27 of 42 in the placebo group (64.3%). Vancomycin-resistant Enterococcus carriage was found in 15 of 30 patients in the oral vancomycin group (50.0%) and 6 of 25 in the placebo group (24.0%) (P = .048) 8 weeks after treatment.Conclusions and RelevanceIn this randomized clinical trial, the incidence of recurrent CDI was lower (though did not reach significance) in participants taking oral vancomycin compared with those taking placebo. Because the study was underpowered, it was unable to reveal firm conclusions about the efficacy (or lack thereof) of vancomycin prophylaxis with respect to recurrent CDI.Trial RegistrationClinicalTrials.gov Identifier: NCT03462459
The Evaluation of Computer Vision-Based Automated Performance Metrics for Endoscopic Kidney Stone Surgery
Cabo, Jackson , Floyd, Chase, Oğuz, İpek , Kavoussi, Nicholas , Cabo, Jackson , Lu, Daiwei , Koyama, Tatsuki

Journal of Endourology | July 2, 2025 | Volume: 39 | Issue: 9 | Pages: 924-929

10.1089/end.2024.0895 | PMID 40601841 Get It

Background: The assessment of surgical competency is essential for clinical training and safety. No objective, real-time tools exist to evaluate competency during endoscopic stone operation. We sought to apply endoscopic computer vision models to define automated performance metrics (APMs) from videos of flexible ureteroscopy. Materials and Methods: We assessed three APMs for endoscopic treatment of kidney stones, including percentage of frames without stone visibility, screen occupancy by stone, and frame-to-frame change in stone occupancy. Surgical videos of a surgeon performing either stone localization or stone ablation were recorded. Using our previously validated computer vision model for endoscopic stone segmentation, APMs were compared between experts (fellowship-trained endourologists) and trainees. Results: Forty-six videos, including 28 of stone localization and 18 of stone laser ablation, were analyzed from nine surgeons (three experts and six trainees). During stone localization, trainee videos had a higher percentage of frames without visible stone (4% vs 27%, p < 0.01) and lower screen occupancy by stone (5% vs 14%, p = 0.03) compared with expert videos. During laser ablation, trainee videos had a higher frame-to-frame change in stone occupancy (3% vs 2%, p < 0.01) compared with expert videos. Conclusions: APMs from computer vision methods differ between expert and trainee surgical videos of endoscopic kidney stone treatment. These metrics could be used to objectively assess skill evaluation and acquisition.